trial

Academic-Community EPINET (AC-EPINET)

NCTId NCT04497857
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 74 (actual)
Sponsored by Indiana University
Primary completion 2025-07-29
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
74 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2022-03-16
Primary completion
2025-07-29
Eligibility
ALL · 16 Years · 35 Years

Interventions & indications

Drugs
Coordinated Specialty Care (CSC)

Sponsors

Indiana UniversityLead Sponsor
University of MichiganCollaborator
Ohio State UniversityCollaborator
Vanderbilt University Medical CenterCollaborator
Tulane UniversityCollaborator
University of RochesterCollaborator
Yale UniversityCollaborator
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Alan Breier, MDPrincipal Investigator

Sites

6 total
Indianapolis, United StatesNew Orleans, United StatesAnn Arbor, United StatesRochester, United StatesColumbus, United StatesNashville, United States

Facts & assertions

4 sourced
Enrollment
74
Phase
NA
Primary Completion Date
2025-07-29
Status
COMPLETED
relationships
The graph out of here
drug
Coordinated Specialty Care (CSC)
drug
lead_sponsor
Indiana University
company
collaborator
University of Michigan
company
Ohio State University
company
indication
Schizophreniform Disorders
indication
Schizoaffective Disorder
indication
Psychotic Disorders
indication
investigator
Alan Breier, MD
person